This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Lung Cancer
  • /
  • Survival analysis for non-squamous NSCLC patients ...

Survival analysis for non-squamous NSCLC patients harbored STK11 or KEAP1 mutation receiving atezolizumab

Read time: 1 mins
Published:31st Mar 2021
Author: Shang X, Li Z, Sun J, Zhao C, Lin J, Wang H.
Source: Lung Cancer
Availability: Pay for access, or by subscription
Ref.:Lung Cancer. 2021 Apr;154:105-112.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest